MacroGenics Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Hello, everyone. Thanks for joining us. My name is Jonathan Chang. I'm part of the SVB Leerink equity research team. It's my pleasure to host the management team of MacroGenics. And we have with us today, President and CEO, Scott Koenig.
For the investors joining us, feel free to submit questions or e-mail them to me at [email protected].
So let's get started. Scott, would you like to briefly introduce the company?
Thanks, Jonathan. Thanks for the opportunity to present today. This is an exciting time for MacroGenics. As you know, we had a great 2020, and we expect a very exciting 2021 as well. The company is about 20 years old. We're focused on immune-based therapeutics. We are a fully integrated company that does everything from early discovery, and we're about to launch our first molecule.
The company has developed 3 proprietary technologies, one
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
